Table 5

Biopsy MMP:E-cadherin ratio in patients of intermediate clinical stage, GS, and serum PSA

No. of patientsStage correctly classified No. of pts. (%)Stage misclassified No. of pts. (%)P
Clinical Stage
 T2b & c
 BX MMP:E-cadherina3328 (85)5 (15)<0.0001
GS 7
 BX MMP:E-cadherina1915 (79)4 (21)0.005
Serum PSA
 10–20 ng/ml
 BX MMP:E-cadherina1916 (84)3 (16)0.002
  • a BX MMP:E-cadherin ratio within the specified group.